|
Originally published In Press as doi:10.1074/jbc.M306283200 on September 5, 2003
J. Biol. Chem., Vol. 278, Issue 46, 45128-45134, November 14, 2003
Cloning and Characterization of ALX, an Adaptor Downstream of CD28*
Tiffani A. Greene,
Penda Powell,
Chima Nzerem,
Michael J. Shapiro, and
Virginia Smith Shapiro
From the
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
T cell activation requires two signals: specific recognition of antigen through the T cell receptor (TCR) and a costimulatory signal provided primarily by CD28 in naïve T cells. We cloned a novel gene with considerable homology to RIBP/TSAd/Lad, an adaptor involved in T cell activation and interleukin-2 (IL-2) promoter activation. Expression of this gene is limited to the spleen and thymus. We have named this gene ALX, adaptor in lymphocytes of unknown function X. Because the related adaptor RIBP is involved in IL-2 regulation, we investigated whether ALX had a similar function. ALX overexpression in Jurkat T cells results in inhibition of IL-2 promoter activation after stimulation with superantigen. The IL-2 promoter contains several binding sites for transcription factors including the composite element RE/AP, which is the primary site of CD28 transcriptional activation. ALX overexpression had the greatest effect on the activation of a RE/AP reporter as opposed to an AP-1 reporter. Interestingly, ALX overexpression strongly inhibited RE/AP activation in response to anti-CD28/phorbol 12-myristate 13-acetate (PMA) stimulation but had minimal effect when anti-TCR/PMA was used. Therefore, it appears that ALX may function downstream of CD28 costimulation during T cell activation. In addition, the mobility of ALX shifts upon TCR/CD28 costimulation to a greater extent than what is observed with either stimulus alone demonstrating that ALX is a target of both TCR and CD28 costimulatory signaling pathways.
Received for publication, June 13, 2003
, and in revised form, August 27, 2003.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY319652 and AY319653.
* This work was supported by a Leukemia and Lymphoma Society Special Fellowship (to V. S. S.) and a grant from the Arthritis Foundation (Arthritis Investigator Award to V. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: 288 John Morgan Bldg., Dept. of Pathology and Laboratory Medicine, University of Pennsylvania, 3620 Hamilton Walk, Philadelphia, PA 19104. Tel.: 215-573-9260; Fax: 215-898-4227; E-mail: shapirov{at}mail.med.upenn.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Shapiro, C. T. Nguyen, H. Aghajanian, W. Zhang, and V. S. Shapiro
Negative Regulation of TCR Signaling by Linker for Activation of X Cells via Phosphotyrosine-Dependent and -Independent Mechanisms
J. Immunol.,
November 15, 2008;
181(10):
7055 - 7061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Lapinski, J. A. Oliver, L. A. Kamen, E. D. Hughes, T. L. Saunders, and P. D. King
Genetic Analysis of SH2D4A, a Novel Adapter Protein Related to T Cell-Specific Adapter and Adapter Protein in Lymphocytes of Unknown Function, Reveals a Redundant Function in T Cells
J. Immunol.,
August 1, 2008;
181(3):
2019 - 2027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Perchonock, A. G. Pajerowski, C. Nguyen, M. J. Shapiro, and V. S. Shapiro
The Related Adaptors, Adaptor in Lymphocytes of Unknown Function X and Rlk/Itk-Binding Protein, Have Nonredundant Functions in Lymphocytes
J. Immunol.,
August 1, 2007;
179(3):
1768 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Perchonock, M. C. Fernando, W. J. Quinn III, C. T. Nguyen, J. Sun, M. J. Shapiro, and V. S. Shapiro
Negative Regulation of Interleukin-2 and p38 Mitogen-Activated Protein Kinase during T-Cell Activation by the Adaptor ALX.
Mol. Cell. Biol.,
August 1, 2006;
26(16):
6005 - 6015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Herrin and L. B. Justement
Expression of the Adaptor Protein Hematopoietic Src Homology 2 is Up-Regulated in Response to Stimuli That Promote Survival and Differentiation of B Cells
J. Immunol.,
April 1, 2006;
176(7):
4163 - 4172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Marti, G. G. Garcia, P. E. Lapinski, J. N. MacGregor, and P. D. King
Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells
J. Exp. Med.,
February 21, 2006;
203(2):
281 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Shapiro, Y.-Y. Chen, and V. S. Shapiro
The Carboxyl-terminal Segment of the Adaptor Protein ALX Directs Its Nuclear Export during T Cell Activation
J. Biol. Chem.,
November 18, 2005;
280(46):
38242 - 38246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Herrin, A. L. Groeger, and L. B. Justement
The Adaptor Protein HSH2 Attenuates Apoptosis in Response to Ligation of the B Cell Antigen Receptor Complex on the B Lymphoma Cell Line, WEHI-231
J. Biol. Chem.,
February 4, 2005;
280(5):
3507 - 3515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Shapiro, P. Powell, A. Ndubuizu, C. Nzerem, and V. S. Shapiro
The ALX Src Homology 2 Domain Is Both Necessary and Sufficient to Inhibit T Cell receptor/CD28-mediated Up-regulation of RE/AP
J. Biol. Chem.,
September 24, 2004;
279(39):
40647 - 40652.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|